Temozolomide—the jack of all gliomas? Reviewing the interim results of the CATNON trial for 1p/19q non-co-deleted anaplastic glioma

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/30DF7C46.svg?ark=w1%2F20260515%2F30DF7C46)](https://nobleid.org/work/w1/20260515/30DF7C46)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors